Skip to main content

Table 2 Differences in the prevalence rates of HBV & HCV infection based on patients’ categorical variables (n:637)

From: Seroprevalence and risk factors of HBV, HCV and HIV among hemodialysis patients: a multicenter cross-sectional study from Damascus Syria

Variable

Positive HBsAg

N (%)

P-value

Positive HCV-Ab

N (%)

P-value

Hemodialysis center

1

9 (3.6%)

0.06

105 (41.5%)

< 0.001

2

5 (3.4%)

18 (12%)

3

5 (3.4%)

16 (11%)

4

0 (0%)

1 (1.3%)

5

0 (0%)

0 (0.0%)

Had HBV Vaccine

Yes

7 (1.6%)

< 0.001

107 (23.8%)

0.977

No

15 (8%)

45 (23.9)

Having Diabetes

Yes

4 (3%)

0.738

22 (16.4%)

0.023

No

18 (3.6%)

130 (25.8%)

Having Hypertension

Yes

17 (3.2%)

0.369

121 (22.6%)

0.079

No

5 (5%)

31 (30.7%)

Having CVD

Yes

7 (2.9%)

0.524

57 (23.4%)

0.815

No

15 (3.8%)

95 (24.2%)

Had dental Procedures

Yes

16 (3.5%)

0.983

93 (20.1%)

< 0.001

No

6 (3.4%)

59 (33.7%)

Had GI endoscopy

Yes

12 (4.8%)

0.135

63 (25.2%)

0.524

No

10 (2.6%)

89 (23%)

Underwent blood transfusion

Yes

17 (3.9%)

0.357

123 (28.3%)

< 0.001

No

5 (2.5%)

29 (14.4%)

Previous use of parenteral drugs

Yes

7 (3.1%)

0.692

58 (25.4%)

0.486

No

15 (3.7%)

94 (23%)

Kidney transplantation

Yes

1 (2.8%)

0.819

10 (27.8%)

0.570

No

21 (3.5%)

142 (23.6%)

Number of hemodialysis sessions per week

2

19 (3.3%)

0.874

134 (23.6%)

0.570

3

3 (4.5%)

18 (26.9%)